Aim: The present study was designed to assess the effect of standardized proanthocyanidin on postprandial blood glucose level after maltose load in non diabetic females. Methods: Single oral dose (50 g) of proanthocyanidin tablet was administered by non diabetic adult females thirty minutes before oral ingestion of maltose load (50 g) using acarbose as comparator. Blood glucose was monitored before and 15, 30, 60, 120, and 180 min post ingestion of maltose. Results: The results showed considerable decrease in 30 and 60 min postprandial hyperglycemia due to the use of proanthocyanidin, while non significant decrease of Area under the Curve (AUC) and delta AUC was obtained in both proanthocyanidin and acarbose groups compared with control. However, comparable results for 2 hr postprandial hyperglycemia were achieved by proanthocyanidin (41%) and acarbose (40%). Conclusion: single oral dose of proanthocyanidin attenuates hyperglycemia after maltose challenge in non-diabetic females and such effect was comparable to that produced by acarbose.
INTRODUCTION
Diabetes mellitus a metabolic disorder of multiple etiology characterized by chronic hyperglycemia and glucose intolerance with impaired metabolism of glucose and other energy yielding fuels (proteins and lipids) resulting from defect in insulin secretion, impaired effectiveness of insulin's action, or combination of both [1] [2] [3] .
Diabetic patients and those with untreated postprandial hyperglycemia are at increased risk of development long-term macro and micro vascular complications including atherosclerosis which may result in stroke and ischemic heart disease, retinopathy, neuropathy and nephropathy [3] . Therefore, effective blood glucose control is the key for preventing or reversing diabetic complications and improving quality of life [4] . Emerging evidence suggests that postprandial hyperglycemia induces glucose toxicity and deteriorates β-cells function [5] ; in addition, it associates with elevated glycosylated hemoglobin and contributes to vascular complications [6] . As the postprandial hyperglycemia mostly related to the amount of digested and absorbed carbohydrates, therefore intervention by inhibiting enzymes involve in the digestion of poly and disaccharides like α-amylase and α-glucosidase, or by slowing the intestinal absorption of glucose represent an important approach in reducing the level of postprandial hyperglycemia [7, 8] .
Currently, although the available oral hypoglycemic drugs can alleviate diabetes, they have many limitations including secondary failure rates, improper pharmacokinetic properties and side effects [4] . Accordingly, complementary and alternative approaches are highly considered, including the adjuvant use of medicinal herbs and dietary phytochemicals with anti-hyperglycemic activities to improve the quality of life in diabetic patients [9, 10] . Polyphenols are a large and heterogenous group of phytochemicals of plant-based foods, such as tea, berries, wine and grape. Several studies indicated that consumption of plant foods is associated with lowered risk of major chronic diseases including diabetes and cardiovascular diseases [11, 12] . Extensive research suggests that the proanthocyanidins isolated from grape seeds are beneficial in many health problems due to their antioxidant effects which found to be 20 times greater than vitamin E and 50 times greater than vitamin C [13, 14] . Recently, in vitro studies have shown that procyanidins protect against free radical mediated cardiovascular and renal disorders [15, 16] . Other studies indicated that various dietary polyphenols may influence carbohydrate metabolism and regulate glucose homeostasis in diabetic rats [17] . Moreover, it has been reported that flavonoids inhibit α-amylase and α-glucosidase activities in vitro [18] ; however, no clear in vivo evidence available for the effect of proanthocyanidin on postprandial hyperglycemia in response to disaccharide load.
Therefore, the present study was designed to evaluate the effect of single oral dose of standardized proanthocyanidin on glucose tolerance after maltose challenge in non diabetic females.
MATERIALS AND METHODS
This study was carried out on six non diabetic females in the College of Pharmacy/ Baghdad University, with mean age 21.6 years, BMI 21.5 kg/m 2 and fasting blood glucose concentration of 106.2 mg/dL, in an open label, placebo controlled cross-over design. The study protocol was approved by the Research Ethics Committee, College of Pharmacy, University of Baghdad. Initially the health status of all subjects was reported, they do not have any previous or current disease, not use any medication or nutrient supplements known to influence blood glucose regulation and all have normal physical activity. Each female was enrolled thrice in 3 hr tolerance tests on separate days, with least 7 days washout period. The subjects were informed to avoid consuming flavonoids containing food as grapes, berries, tea, coffee, dark chocolate and soft drinks for at least three days before the day of the experiment. The maltose load test was performed in the morning after 12 hr overnight fasting. Blood samples were obtained from a fingertip using a lancing device, and glucose level was estimated representing zero time measurement (fasting glucose). A cross-over design of treatment was followed through which subjects were randomized into control and test (three subjects for each group). A washout period of 72 hr was followed before the next experiment; after an overnight fasting, either single 50mg tablet of proanthocyanidin, 100 mg tablet acarbose, or placebo was orally ingested. Thirty minutes following administration of doses, each individual consumed 50 g of maltose mixed in 250 ml water. Blood glucose level was estimated before and at 15, 30, 60, 90, 120 and 180 min using glucose oxidaseperoxidase reactive strips and a glucometer (ACCUcheck, Germany). The total blood glucose over 3 hours was expressed as integrated area under curve for glucose (AUC 0-180 ), while the change in blood glucose from the basal level after maltose load was analyzed and represented as delta blood glucose expressed as (delta AUC).
Statistical Analysis
The data were expressed as mean±SD. The change in plasma glucose level with respect to baseline and time was estimated to represent area under the curve. Statistical significance was performed by one way factorial analysis of variance (ANOVA), followed by Benferroni's post hoc comparisons to compare means of AUC, using graph-pad prism 5 for windows software. P values less than 0.05 were considered to be statistically significant.
RESULTS
Ingestion of maltose (50 g) increases blood glucose level in normal control individuals and maximum concentration (C max ) of glucose (180.8 mg/dl) was achieved within 60 min (T max ) after ingestion of maltose, while pretreatment with both acarbose and proanthocyanidin resulted in C max of 156.5 and 141.8 mg/dl respectively, 30 min post maltose load (Figure 2 ; table 1). In control group, the average increment of blood glucose was 62.5mg/dl after 30 min of maltose load, while acarbose produces 54.2 mg/dl increase at the same time. In proanthocyanidin group, the 30 min post-load glucose increased only by 36.8 mg/dl indicating that proanthocyanidin reduced the postprandial glucose elevation (Figure 3) . Although proanthocyanidin-maltose load seems to be well tolerated, estimation of integrated AUC 0-180 and delta AUC over 3 hr period revealed that proanthocyanidin did not show significant results compared to control; similar result was obtained with acarbose (Figures 4  and 5; table 2 ). The percent decrement of blood glucose produced by both proanthocyanidin and acarbose was found to increase with time to reach maximum (103.1 % and 97.5 % respectively) after 1 hr of maltose load, then return to about 41.31 % and 40.17% 2 hr postprandial compared to control group. 
DISCUSSION
Rapid absorption of glucose challenges the regulatory mechanisms of glucose homeostasis, and habitual consumption of high glycemic diets may therefore increase the risk of diabetic complications and cardiovascular diseases. Acute hyperglycemia was reported to induce endothelial dysfunction and result in microvascular damage through oxidation of low density lipoprotein (LDL) and other proatherogenic mechanisms [19] . Diet rich in carbohydrates produces sharp rise in the blood glucose level as the complex carbohydrates in the food is rapidly absorbed in the intestine aided by the effect of the digestive enzymes α-amylase and α-glucosidase which break dietary carbohydrates into absorbable glucose [20] .
Actually, controlling postprandial plasma glucose level is critical in the early treatment of diabetes mellitus (DM) and in reducing chronic vascular complications. So, inhibition of enzymes that digest complex carbohydrates would reduce the rate of glucose release and absorption, and consequently suppress postprandial hyperglycemia [21] . Previous study reported the anti-postprandial hyperglycemic effect of grape flavonoids and phenolic compounds in diabetic mice, suggesting the valuable benefit of these bioactive products in management of impaired blood glucose levels in type II diabetes mediated by their capacity to inhibit α-glucosidase activity, the crucial enzyme for digestion of maltose into absorbable glucose [22] ; so, we evaluate the effect of standardized grape seed extract (95% proanthocyanidin) on postprandial hyperglycemia after maltose load in healthy individuals. The reported data in the present study showed that proanthocyanidin provided significant tolerance for 30 and 60 min postprandial hyperglycemia relative to untreated control, while only 60 min tolerance was achieved by acarbose indicating the potency of proanthocyanidin to attenuate postprandial hyperglycemic spikes and alleviate oral glucose tolerance test (OGTT) better than acarbose. On the other hand, both treatments provided statistically non significant support to alter the disposal after an OGTT in healthy, non diabetic young women as indicated by the results of AUC 0-180 and delta AUC 0-180 . Considering that, it's possible that further study with older individuals and/or those with impaired glucose tolerance would provide more robust effects. Moreover, as subjects simply ingested a single dose 30 min before maltose load, it is possible that chronic intake for a period of weeks (as for most oral hypoglycemic agents) may provide additional benefit. Also further study is needed to investigate such hypotheses, possibly including both men and women. In fact, the phytochemical analysis reported on α-glucosidase inhibitors isolated from medicinal plants suggests that several potential inhibitors belong to dietary polyphenols has a characteristic structural features to inhibit the α-glucosidase enzyme [23] , which may be varied together with the antioxidant activity by the polyphenolic structure of proanthocyanidin [24] . In terms of overall effects, our data are not as strong as those obtained from the animal studies of Hogan et al, who reported favorable effects on glucose tolerance in response to treatment with grape pomace proanthocyanidin [18] . It is possible that differences in the usual response between animals and humans contributed to these mixed findings, coupled with the fact that our subjects were all healthy and nondiabetic. As stated above, while the condition effect for glucose was not of statistical significance, roughly all subjects responded to proanthocyanidin treatment better than acarbose, a well known clinically used α-glucosidase inhibitor, evidenced by lower glucose in response to the maltose load, especially within the first hr after load. In spite of the non-significant results, our findings may provide practical aid for selected individuals opting to use such dietary supplement for glucose disposal after carbohydrate-rich diet. Moreover, we believe that our findings for a response in non-diabetic individuals, with normal fasting glucose and normal glucose tolerance, provide justification for future studies inclusive of larger sample sizes of individuals with impaired glucose tolerance (i.e., diabetic, pre-diabetic). As has been noted for many dietary supplements, a relatively high degree of subject variability in response to treatment was observed which, when coupled with our relatively small sample size, limit the chances for detecting statistically significant findings. As this was a pilot study designed to determine whether proanthocyanidin has an application in larger trials involving diabetic and pre-diabetic patients, our small sample size is justified, and we believe that our objective was met. That is, our results merit attention in future to larger scale trials, in particular those involving individuals with pre-diabetes or untreated diabetes.
As conclusion, administration of single oral dose of proanthocyanidin results in a slight, albeit nonstatistically significant lowering of blood glucose in response to an oral maltose load in healthy females.
